These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 3140772)
21. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits. Jensen H; Zerouala C; Carrier M; Short B J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826 [TBL] [Abstract][Full Text] [Related]
22. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656 [TBL] [Abstract][Full Text] [Related]
23. Ocular Permeation of Topical Tazocin and Its Effectiveness in the Treatment of Pseudomonas aeruginosa Induced Keratitis in Rabbits. Singh S; Agarwal R; Razak ZA; Ngu R; Nyein LL; Vasudevan S; Kapitonova M; Kadir AJ; Visvaraja S J Ocul Pharmacol Ther; 2018; 34(1-2):214-223. PubMed ID: 29341837 [TBL] [Abstract][Full Text] [Related]
24. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389 [TBL] [Abstract][Full Text] [Related]
25. Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen. Hobden JA; Hill JM; Engel LS; O'Callaghan RJ Antimicrob Agents Chemother; 1993 Sep; 37(9):1856-9. PubMed ID: 8239596 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of topical gentamicin treatment after 193-nm photorefractive keratectomy in an experimental Pseudomonas keratitis model. Frucht-Pery J; Golan G; Hemo I; Zauberman H; Shapiro M Graefes Arch Clin Exp Ophthalmol; 1995 Aug; 233(8):532-4. PubMed ID: 8537030 [TBL] [Abstract][Full Text] [Related]
28. Topical fluconazole for experimental candida keratitis in rabbits. Behrens-Baumann W; Klinge B; RĂ¼chel R Br J Ophthalmol; 1990 Jan; 74(1):40-2. PubMed ID: 2306443 [TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lenses. Hui A; Willcox M; Jones L Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4896-904. PubMed ID: 25028363 [TBL] [Abstract][Full Text] [Related]
30. Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye. Behrens-Baumann W Ophthalmologica; 1996; 210(2):119-22. PubMed ID: 8859488 [TBL] [Abstract][Full Text] [Related]
31. Route of antibiotic administration in bacterial keratitis. Leibowitz HM; Ryan WJ; Kupferman A Arch Ophthalmol; 1981 Aug; 99(8):1420-3. PubMed ID: 6789804 [TBL] [Abstract][Full Text] [Related]
32. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis. Callegan MC; Engel LS; Hill JM; O'Callaghan RJ Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714 [TBL] [Abstract][Full Text] [Related]
33. Two Different Concentrations of Topical Levofloxacin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Keratitis. Tajima K; Miyake T; Koike N; Hattori T; Takahashi H; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H J Ocul Pharmacol Ther; 2015 Dec; 31(10):636-41. PubMed ID: 26348840 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis. Silbiger J; Stern GA Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778 [TBL] [Abstract][Full Text] [Related]
37. Lomefloxacin is an effective treatment of experimental bacterial keratitis. Kowalski RP; Romanowski EG; Yates KA; Gordon YJ Cornea; 2001 Apr; 20(3):306-8. PubMed ID: 11322421 [TBL] [Abstract][Full Text] [Related]